Incidence and clinical relevance of heparin-induced antibodies in patients with deep vein thrombosis treated with unfractionated or low-molecular-weight heparin

British Journal of Haematology

Volumn 118, Issue 4, 2002, Pages 1137-1142

  Lindhoff Last, Edelgard ^a   Nakov, Roumen ^b   Misselwitz, Frank ^b   Breddin, Hans Klaus ^c   Bauersachs, Rupert ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b Knoll AG   (Germany)

^c International Institute of Thrombosis and Vascular Diseases   (Germany)

Author keywords

Deep vein thrombosis; Heparin induced thrombocytopenia; Heparin platelet factor 4 antibodies; Low molecular weight heparin; Unfractionated heparin

Indexed keywords

HEPARIN DERIVATIVE; LOW MOLECULAR WEIGHT HEPARIN; REVIPARIN; THROMBOCYTE FACTOR 4;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DRUG EFFECT; FEMALE; HUMAN; INCIDENCE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTOPENIA;

ANTICOAGULANTS; AUTOANTIBODIES; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEPARIN; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; MALE; MIDDLE AGED; PLATELET FACTOR 4; PROSPECTIVE STUDIES; THROMBOCYTOPENIA; TIME FACTORS; VENOUS THROMBOSIS;

EID: 0036049668     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2002.03687.x     Document Type: Article

References (21)

1. Diagnostic tests in heparin-induced thrombocytopenia
2. Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia
3. Prevalence of heparin-associated antibodies without thrombosis in patients undergoing cardiopulmonary bypass surgery
4. Effects of a low-molecular-weight heparin on thrombus regression and recurrent venous thromboembolism in patients with deep-vein thrombosis
5. Heparin-induced thrombocytopenia
6. Heparin-induced thrombocytopenia: Mechanism of interaction of the heparin-dependent antibody with platelets
7. Heparin-associated thrombocytopenia: Isolation of the antibody and characterization of a multimolecular PF4-heparin complex as the major antigen
8. Heparin-induced antibodies as a risk factor for thromboembolism and haemorrhage in patients undergoing chronic haemodialysis
9. Heparin-related thrombosis despite normal platelet counts in vascular surgery
10. Heparin-induced thrombocytopenia and thrombosis: A prospective analysis of the incidence in patients with heart and cerebrovascular diseases
11. Immunoglobulin G from patients with heparin-induced thrombocytopenia binds to a complex of heparin and platelet factor 4
12. Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home
13. A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis
14. A prospective study on the incidence and clinical relevance of heparin-induced antibodies in patients after vascular surgery
15. Heparin-induced thrombocytopenia in patients treated with unfractionated heparin: Prevalence of thrombosis in a 1 year follow-up
16. Antibodies to platelet factor 4-heparin after cardiopulmonary bypass in patients anticoagulated with unfractionated heparin or a low-molecular-weight heparin
17. Patients treated with unfractionated heparin during open heart surgery are at high risk to form antibodies reactive with heparin-platelet factor 4 complexes
18. Heparin-induced thrombocytopenia
19. Heparin induced thrombocytopenia in patients treated with low molecular-weight heparin or unfractionated heparin
20. Impact of patient population on the risk for heparin-induced thrombocytopenia
21. Detection of PF4-heparin auto-antibodies by ELISA